Related Experiment Video
Updated: Sep 5, 2025

RhoC GTPase Activation Assay
Published on: August 22, 2010
STAT3 mediates RCP-induced cancer cell invasion through the NF-κB/Slug/MT1-MMP signaling cascade
Su Jin Cho1, Bo Young Jeong1,2, Young Soo Song3
1Department of Pharmacology, College of Medicine, Konyang University, 821 Medical Science Building, 158 Gwanjeodong-ro, Seo-gu, Daejeon, 35365, Republic of Korea.
Abstract:
Rab coupling protein (RCP) has been known to induce cancer invasion and metastasis, and STAT3 is one of major oncogenic factors. In the present study, we identify the critical role of STAT3 in RCP-induced cancer cell invasion. Immunohistochemical data of ovarian cancer tissues presented that levels of RCP expression are closely correlated with those of phospho-STAT3 (p-STAT3). In addition, ovarian cancer patients with high expression of both RCP and p-STAT3 had significantly lower progress-free and overall survival rates compared to those with low either RCP or p-STAT3 expression. Mechanistically, RCP induced STAT3 phosphorylation in both ovarian and breast cancer cells. Silencing or pharmacological inhibition of STAT3 significantly inhibited RCP-induced cancer cell invasion. In addition, we provide evidence that the β1 integrin/EGFR axis is important for RCP-induced STAT3 phosphorylation. Furthermore, STAT3 activated NF-κB for Slug expression that in turn upregulated MT1-MMP expression for cancer cell invasion. Collectively, our present data demonstrate that STAT3 is located downstream of the β1 integrin/EGFR axis and induces Slug and MT1-MMP expression for cancer cell invasion.
Insights
Rab coupling protein (RCP) drives cancer invasion by activating STAT3 signaling. Inhibiting STAT3 blocks RCP-induced metastasis, revealing a key pathway for therapeutic targeting in ovarian and breast cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Rab coupling protein (RCP) is implicated in cancer invasion and metastasis.
- Signal transducer and activator of transcription 3 (STAT3) is a known oncogenic factor involved in cancer progression.
Purpose of the Study:
- To elucidate the critical role of STAT3 in RCP-induced cancer cell invasion.
- To investigate the molecular mechanisms linking RCP, STAT3, and cancer metastasis.
Main Methods:
- Immunohistochemistry on ovarian cancer tissues to correlate RCP and phospho-STAT3 (p-STAT3) expression.
- In vitro studies involving cancer cell lines to assess RCP's effect on STAT3 phosphorylation.
- Gene silencing and pharmacological inhibition of STAT3 to evaluate its impact on invasion.
- Analysis of the β1 integrin/EGFR axis and downstream signaling pathways including NF-κB, Slug, and MT1-MMP.
Main Results:
- High RCP and p-STAT3 expression correlated with lower survival rates in ovarian cancer patients.
- RCP induced STAT3 phosphorylation in ovarian and breast cancer cells.
- STAT3 inhibition significantly reduced RCP-induced cancer cell invasion.
- The β1 integrin/EGFR axis was identified as crucial for RCP-induced STAT3 phosphorylation.
- STAT3 activation of NF-κB led to Slug and MT1-MMP upregulation, promoting invasion.
Conclusions:
- STAT3 is a critical mediator of RCP-induced cancer invasion and metastasis.
- The β1 integrin/EGFR/STAT3/NF-κB/Slug/MT1-MMP axis represents a key pathway in RCP-driven cancer progression.
- Targeting STAT3 may offer a therapeutic strategy against RCP-mediated invasion and metastasis.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Intracellular Signaling Affects Focal Adhesions
Some...
MAPK Signaling Cascades
Cancer Cell Migration through Invadopodia
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

